{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T11:36:50Z","timestamp":1778585810218,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T00:00:00Z","timestamp":1528934400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.jid.2018.05.028","type":"journal-article","created":{"date-parts":[[2018,6,14]],"date-time":"2018-06-14T04:24:25Z","timestamp":1528950265000},"page":"2635-2643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental\u00a0Actinic Keratoses"],"prefix":"10.1016","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0711-7856","authenticated-orcid":false,"given":"Vered","family":"Behar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadas","family":"Pahima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Kozminsky-Atias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Arbel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Loeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Herzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oren M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2018.05.028_bib1","doi-asserted-by":"crossref","first-page":"23152","DOI":"10.1074\/jbc.M112.345918","article-title":"Mediation of the antiapoptotic activity of Bcl-xL protein upon interaction with VDAC1 protein","volume":"287","author":"Arbel","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2018.05.028_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/1011-1344(94)07080-8","article-title":"Chronic UVB- and all-trans retinoic-acid-induced qualitative and quantitative changes in hairless mouse skin","volume":"28","author":"Chaquour","year":"1995","journal-title":"J\u00a0Photochem Photobiol B"},{"key":"10.1016\/j.jid.2018.05.028_bib3","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/jid.2011.418","article-title":"Ingenol mebutate field-directed treatment of UVB-damaged skin reduces lesion formation and removes mutant p53 patches","volume":"132","author":"Cozzi","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jid.2018.05.028_bib4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.bbrc.2008.01.026","article-title":"A\u00a0dicyanotriterpenoid induces cytoprotective enzymes and reduces multiplicity of skin tumors in UV-irradiated mice","volume":"367","author":"Dinkova-Kostova","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jid.2018.05.028_bib5","first-page":"522","article-title":"Combined in\u00a0vitro\/in\u00a0vivo test procedure with human tumor xenografts for anticancer drug development","volume":"165","author":"Fiebig","year":"1989","journal-title":"Strahlenther Onkol Organ Dtsch Rontgengesellschaft Al"},{"key":"10.1016\/j.jid.2018.05.028_bib6","doi-asserted-by":"crossref","first-page":"4636","DOI":"10.1038\/onc.2008.108","article-title":"Methyl jasmonate binds to and detaches mitochondria-bound hexokinase","volume":"27","author":"Goldin","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.jid.2018.05.028_bib7","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1101\/gad.889901","article-title":"Inhibition of early apoptotic events by Akt\/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase","volume":"15","author":"Gottlob","year":"2001","journal-title":"Genes Dev"},{"key":"10.1016\/j.jid.2018.05.028_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jid.2018.05.028_bib9","doi-asserted-by":"crossref","first-page":"e17674","DOI":"10.1371\/journal.pone.0017674","article-title":"Subcellular localization of hexokinases I and II directs the metabolic fate of glucose","volume":"6","author":"John","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jid.2018.05.028_bib10","first-page":"1289","article-title":"Histogenesis and progression in ultraviolet light-induced tumors in hairless mice","volume":"67","author":"Kligman","year":"1981","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.jid.2018.05.028_bib11","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1517\/14728222.2013.833607","article-title":"Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy","volume":"17","author":"Krasnov","year":"2013","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.jid.2018.05.028_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s10495-014-1051-7","article-title":"The Bcl-2 family: structures, interactions and targets for drug discovery","volume":"20","author":"Kvansakul","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.jid.2018.05.028_bib13","doi-asserted-by":"crossref","first-page":"32586","DOI":"10.18632\/oncotarget.15937","article-title":"Deguelin inhibits non-small cell lung cancer via down-regulating Hexokinases II-mediated glycolysis","volume":"8","author":"Li","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jid.2018.05.028_bib14","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-017-0530-4","article-title":"Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2","volume":"36","author":"Li","year":"2017","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.jid.2018.05.028_bib15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1021\/acsmedchemlett.5b00214","article-title":"Discovery of a novel 2,6-disubstituted glucosamine series of potent and selective hexokinase 2 inhibitors","volume":"7","author":"Lin","year":"2016","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.jid.2018.05.028_bib16","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-cellbio-092910-154237","article-title":"Aerobic glycolysis: meeting the metabolic requirements of cell proliferation","volume":"27","author":"Lunt","year":"2011","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.jid.2018.05.028_bib17","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(09)61196-X","article-title":"Non-melanoma skin cancer","volume":"375","author":"Madan","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2018.05.028_bib18","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.molcel.2004.11.014","article-title":"Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak","volume":"16","author":"Majewski","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.jid.2018.05.028_bib19","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000076016","article-title":"Actinic keratosis: the key event in the evolution from photoaged skin to squamous cell carcinoma. Therapy based on pathogenetic and clinical aspects","volume":"17","author":"Oppel","year":"2004","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.jid.2018.05.028_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10863-008-9148-8","article-title":"Regulation of hexokinase binding to VDAC","volume":"40","author":"Pastorino","year":"2008","journal-title":"J\u00a0Bioenerg Biomembr"},{"key":"10.1016\/j.jid.2018.05.028_bib21","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.1074\/jbc.M109950200","article-title":"Mitochondrial binding of hexokinase II inhibits Bax-induced cytochrome c release and apoptosis","volume":"277","author":"Pastorino","year":"2002","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jid.2018.05.028_bib22","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ccr.2013.06.014","article-title":"Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer","volume":"24","author":"Patra","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jid.2018.05.028_bib23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0005-2728(02)00248-7","article-title":"Mitochondrial bound type II hexokinase: a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention","volume":"1555","author":"Pedersen","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jid.2018.05.028_bib24","first-page":"1045","article-title":"Aberrant expression of the glycolytic enzymes aldolase B and type II hexokinase in hepatocellular carcinoma are predictive markers for advanced stage, early recurrence and poor prognosis","volume":"19","author":"Peng","year":"2008","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jid.2018.05.028_bib25","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1177\/0194599813476845","article-title":"Curcumin inhibits UV radiation-induced skin cancer in SKH-1 mice","volume":"148","author":"Phillips","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.jid.2018.05.028_bib26","first-page":"977","article-title":"Early p53-positive foci as indicators of tumor risk in ultraviolet-exposed hairless mice: kinetics of induction, effects of DNA repair deficiency, and p53 heterozygosity","volume":"61","author":"Rebel","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.jid.2018.05.028_bib27","first-page":"251","article-title":"Expression of type 2 hexokinase and mitochondria-related genes in gastric carcinoma tissues and cell lines","volume":"27","author":"Rho","year":"2007","journal-title":"Anticancer Res"},{"issue":"Suppl. 3","key":"10.1016\/j.jid.2018.05.028_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1365-2133.2007.07860.x","article-title":"Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification","volume":"156","author":"R\u00f6wert-Huber","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2018.05.028_bib29","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.bbamem.2014.10.040","article-title":"The mitochondrial voltage-dependent anion channel 1 in tumor cells","volume":"1848","author":"Shoshan-Barmatz","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jid.2018.05.028_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fonc.2012.00164","article-title":"VDAC1: from structure to cancer therapy","volume":"2","author":"Shoshan-Barmatz","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.jid.2018.05.028_bib31","first-page":"170","article-title":"Mammalian hexokinases and their abnormal expression in cancer","volume":"57","author":"Smith","year":"2000","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.jid.2018.05.028_bib32","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1242\/jeb.00241","article-title":"Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function","volume":"206","author":"Wilson","year":"2003","journal-title":"J\u00a0Exp Biol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18320566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X18320566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T14:33:51Z","timestamp":1604414031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X18320566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S0022202X18320566"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2018.05.028","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental\u00a0Actinic Keratoses","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2018.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier, Inc. on behalf of the Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}